GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

GuruFocus Names Ten Dividend Growers: July 22 to 26

July 29, 2013 | About:
Monica Wolfe

Monica Wolfe

119 followers
During the past week, GuruFocus recognized 10 companies as dividend growers. In order to be qualified for this list, the company had to:

· Have a dividend yield of greater than 3%.

· Have a strong history of stable and increasing dividends.

· Maintain guru ownership.

· Have a market cap of greater than $10 billion.

The following five companies came from all sectors of the market, but they all fit the necessary criteria needed to qualify them as dividend growers. The other five dividend growers of the week were reported in energy companies and can be found here.

A comparison of the companies’ historical dividend growth:

1375129721269.png

Merck & Co Inc. (MRK)

On July 25, Merck & Co. declared a dividend of $0.43 per share, representing a 3.5% dividend yield for the company. This dividend is payable on Oct. 7 to shareholders of the record at the close of business on Sept. 16, 2013.

The company’s historical dividend growth is as follows:

· 10-year: 1.3%

· 5-year: 2.4%

· 3-year: 2.7%

1375117153111.png

Merck has a -7.9% share buyback rate, the company’s dividend yield is currently at a 5-year low and the company’s dividend payout rate is currently at 86.67%. View more of Merck’s dividend information on the new Dividend Page.

Merck is a global, research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Merck’s historical price, revenue and net income:

1375117389664.png

Merck has a market cap of $145.49 billion. Its shares are currently trading at around $48.50 with a P/E ratio of 24.80, a P/S ratio of 3.20 and a P/B ratio of 2.70. The company had an annual average earnings growth of 1.8% over the past ten years.

There are currently 31 gurus that hold a position in Merck & Co. Click here to see these gurus’ holding histories.

Intel Corp. (INTC)

On July 25, Intel declared a dividend of $0.225 per share, representing a 3.90% dividend yield for the company. This dividend is payable on Sept. 1 to shareholders of the record at the close of business on Aug. 7, 2013.

The company’s historical dividend growth is as follows:

· 10-year: 25.3%

· 5-year: 13.4%

· 3-year: 11.6%

1375119117121.png

Intel has a 2.2% share buyback rate along with a 7.31% yield on cost and a 44.04% dividend payout ratio. To see more historical dividend information on Intel, check out the company’s Dividend Page.

Intel is a semiconductor chip maker, which develops advanced integrated digital technology products, mainly integrated circuits, for industries such as computing and communications.

Intel’s historical price, revenue and net income:

1375119407375.png

Intel has a market cap of $114.48 billion. Its shares are currently trading at around $23.23 with a P/E ratio of 11.60, P/S ratio of 2.30 and P/B ratio of 2.10. The company had an annual average earnings growth of 8.5% over the past 10 years.

GuruFocus rated Intel the business predictability rank of 3.5-star.

There are currently 36 gurus that hold positions in Intel. Click here to see their holding histories.

GlaxoSmithKline PLC (GSK)

On July 25, GlaxoSmithKline declared a dividend of $0.553 per share, representing a 4.60% dividend yield for the company. This dividend is payable on Oct. 3 to shareholders of the record at the close of business on Aug. 9, 2013.

The company’s historical dividend growth is as follows:

· 10-year: 7.1%

· 5-year: 6.8%

· 3-year: 5%

1375125228492.png

GlaxoSmithKline has a 0.6% share buyback rate, a 6.39% yield on cost and a 92.57% dividend payout ratio. Click here to see more dividend data on GlaxoSmithKline.

GlaxoSmithKline creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter medicines and health-related consumer products.

GlaxoSmithKline’s historical price, revenue and net income:

1375125631788.png

GlaxoSmithKline has a market cap of $127.17 billion. Its shares are currently being traded at around $51.38 with a P/E ratio of 20.50, a P/S ratio of 3.10 and a P/B ratio of 13.50. The company has seen an annual average earnings growth of 9.1% over the past ten years.

GuruFocus rated GlaxoSmithKline the business predictability rank of 2-star.

There are currently 18 gurus that hold a position in GSK. Click here to see their holding histories.

HCP Inc. (HCP)

On July 25, HCP declared a dividend of $0.525 per share, representing a 4.50% dividend yield for the company. This dividend is payable on Aug. 20 to shareholders of the record at the close of business on Aug. 5, 2013.

The company’s historical dividend growth is as follows:

· 10-year: 3.4%

· 5-year: 2.3%

· 3-year: 2.1%

1375127736289.png

HCP has a 5.04% yield on cost and a 106.41% dividend payout ratio. Check out more historical dividend data for HCP here.

HCP is a REIT that invests mainly in real estate serving the healthcare industry in the United States. The Company acquires, develops, leases, manages and disposes of healthcare real estate, and provides financing to healthcare providers.

HCP’s historical price, revenue and net income:

1375127930467.png

HCP has a market cap of $20.43 billion. Its shares are currently being traded at around $45.11 with a P/E ratio of 23.70, a P/S ratio of 10.10 and a P/B ratio of 2.00. The company had an annual average earnings growth of 0.3% over the past ten years.

There are currently seven gurus that maintain holdings in HCP. Click here to see their holding histories.

Health Care REIT (HCN)

On July 25, Health Care REIT declared a dividend of $0.765 per share, representing a 4.60% dividend yield for the company. This dividend is payable on Aug. 20 to shareholders of the record at the close of business on Aug. 6, 2013.

The company’s historical dividend growth is as follows:

· 10-year: 2.7%

· 5-year: 2.3%

· 3-year: 2.1%

1375128304938.png

View more dividend information for Health Care REIT here.

Health Care REIT is a REIT that invests in senior housing and health care real estate. The company also provides an array of property management and development services. Its property types include investment properties and medical office buildings.

Health Care REIT’s historical price, revenue and net income:

1375128469932.png

Health Care REIT has a market cap of $18.59 billion. Its shares are trading at around $65.69 with a P/E ratio of 310.40, a P/S ratio of 7.80 and a P/B ratio of 1.90. The company had an average earnings growth of 0.2% over the past five years.

Three gurus currently hold positions in HCN. Click here to see their holding histories.



To view a complete list of high yielding dividend stocks found among the gurus’ portfolios,
click here.

Rating: 3.0/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide